The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy

192 indexed citations
published 2023

Countries where authors are citing The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy

Specialization
Citations

This map shows the geographic impact of The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy more than expected).

Fields of papers citing The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy.

About The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy

This paper, published in 2023, received 192 indexed citations . Written by Hai‐Hao Han, Paramesh Jangili, Mingle Li, Luling Wu, Yi Zang, Adam C. Sedgwick, Jia Li, Xiao‐Peng He, Tony D. James and Jong Seung Kim covering the research area of Molecular Biology, Materials Chemistry and Biomedical Engineering. It is primarily cited by scholars working on Biomedical Engineering (136 citations), Materials Chemistry (78 citations) and Molecular Biology (65 citations). Published in Chemical Society Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1039/d2cs00673a.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026